Today: 13 June 2026
Browse Category

NYSE:FMC 30 October 2025 - 10 February 2026

FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

FMC stock price jumps nearly 7% as traders weigh strategic review and fresh Citi target cut

FMC shares jumped 7% to $16.46 Tuesday morning, extending gains after the company launched a strategic review that could include a sale and warned of weaker 2026 results. Citigroup cut its price target to $14 but kept a Neutral rating. Moody’s downgraded FMC’s debt to junk, citing increased event risk. The company’s annual shareholder meeting is set for April 28.
10 February 2026
·
FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Stock Plunges Over 40% to Multi-Year Low After Shock Loss and Dividend Cut – Is a Turnaround Possible?

FMC Corp shares plunged 42% to $16, their lowest since 2016, after the company posted a $569 million quarterly loss and slashed its dividend by 80%. Revenue fell 49% year-over-year, hit by a $510 million write-down tied to its India business. The company cut its 2024 outlook and announced President Ronaldo Pereira will step down December 15. Analysts downgraded the stock and trimmed price targets.
30 October 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 30.10.2025

US stocks fell Oct. 30, with the S&P 500 down 0.99% and Nasdaq off 1.57%. Oracle shares dropped 6.8% to $256.28 despite analysts raising price targets and maintaining buy ratings. Liberty Latin America slid about 6% in a month, closing near $7.77, well below its $10.63 fair value estimate. Intensity Therapeutics surged nearly 400%, while CERO plunged almost 95%.
30 October 2025
·······

Stock Market Today

  • ChronoScale Stock Soars Amid High Valuation and Losses
    June 13, 2026, 2:14 PM EDT. ChronoScale (CHRN) shares surged 134.18% year-to-date, delivering a 378.12% total return over one year despite a $72.73 million loss on $84.38 million revenue. The Dallas-based AI compute platform's stock trades at a striking price-to-sales (P/S) ratio of 31.3x, far above the US IT sector average of 1.7x and peers at 2.3x. This elevated P/S indicates strong investor expectations for future revenue growth and profitability, though it raises risks if the company fails to meet these projections. Investors are advised to weigh these factors carefully and consider broader AI infrastructure opportunities. The sharp ascent and stretched valuation suggest volatility ahead, making due diligence crucial.

Latest articles

FINRA hits Merrill Lynch with $225,000 fine for 1,600 missed customer complaints

FINRA hits Merrill Lynch with $225,000 fine for 1,600 missed customer complaints

13 June 2026
FINRA fined Merrill Lynch $225,000 and issued a censure after finding the firm failed to report over 1,600 customer complaints from post-call surveys in 2023, citing inadequate supervisory review and violation of reporting rules; Merrill self-disclosed, conducted a lookback, resolved complaints, and suspended written survey comments in January 2024.
Starbucks Stock Price Nears 52-Week High as Turnaround Rally Faces a Valuation Test

Starbucks Stock Price Nears 52-Week High as Turnaround Rally Faces a Valuation Test

13 June 2026
Starbucks closed Friday at $103.04, up 0.74% and just 5% below its 52-week high, as investors await fiscal Q3 results to see if strong traffic can keep offsetting labor and coffee-cost pressure; management recently raised 2026 guidance after reporting 6.2% global comp sales growth and a 9% revenue jump in Q2, but margin declines and a high P/E ratio leave little room for disappointment.
Go toTop